Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1

作者: Ping Xiang , Chaoyu Lo , Bob Argiropoulos , C. Benjamin Lai , Arefeh Rouhi

DOI: 10.1016/J.EXPHEM.2010.06.006

关键词:

摘要: Objective Myeloid ectropic viral integration site 1 ( MEIS1 ) is a Hox cofactor known for its role in development and strongly linked to normal leukemic hematopoiesis. Although previous studies have focused on identifying protein partners of transcriptionally regulated targets, little about the upstream transcriptional regulators this tightly gene. Understanding regulation important understanding hematopoiesis leukemogenesis. Materials Methods Here we describe our focusing evolutionary conserved putative promoter region. Phylogenetic sequence analysis reporter assays MEIS1-expressing (K562) nonexpressing (HL60) cell line models were used identify key regulatory regions potential transcription factor binding sites within candidate region followed by functional expression one identified regulator both lines primary human cord blood leukemia samples. Results Chromatin status associated with expression. Truncation mutation coupled revealed that ETS family member located 289 bp annotated start required activity. Of three members tested, only ELF1 was enriched as assessed electrophoretic mobility shift assay chromatin immunoprecipitation experiments K562. This finding confirmed -expressing Moreover, small interfering RNA−mediated knockdown K562 cells decreased Conclusions We conclude an positive

参考文章(44)
Larry H. Matherly, David L. Becton, Yaddanapudi Ravindranath, Steven A. Buck, Gita V. Massey, Howard J. Weinstein, Xi Huang, Jeffrey W. Taub, Myron N. Chang, Mark L. Stout, Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin. Blood. ,vol. 94, pp. 1393- 1400 ,(1999) , 10.1182/BLOOD.V94.4.1393
Barbara J. Graves, Jeannine M. Petersen, Specificity within the ets Family of Transcription Factors Advances in Cancer Research. ,vol. 75, pp. 1- 57 ,(1998) , 10.1016/S0065-230X(08)60738-1
Nadia Mercader, Esther Leonardo, Natalia Azpiazu, Antonio Serrano, Ginés Morata, Carlos Martínez-A, Miguel Torres, Conserved regulation of proximodistal limb axis development by Meis1/Hth Nature. ,vol. 402, pp. 425- 429 ,(1999) , 10.1038/46580
Saara AittomaÈki, Jie Yang, Edward W Scott, M Celeste Simon, Olli Silvennoinen, Molecular basis of Stat1 and PU.1 cooperation in cytokine‐induced Fcγ receptor I promoter activation International Immunology. ,vol. 16, pp. 265- 274 ,(2004) , 10.1093/INTIMM/DXH037
Takuya Fukushima, Yasushi Miyazaki, Hideki Tsushima, Chizuko Tsutsumi, Jun Taguchi, Shinichiro Yoshida, Kazutaka Kuriyama, David Scadden, Stephen Nimer, Masao Tomonaga, The level of MEF but not ELF-1 correlates with FAB subtype of acute myeloid leukemia and is low in good prognosis cases Leukemia Research. ,vol. 27, pp. 387- 392 ,(2003) , 10.1016/S0145-2126(02)00214-X
Zhi-Jun Duan, Xiangdong Fang, Alex Rohde, Hemei Han, George Stamatoyannopoulos, Qiliang Li, Developmental specificity of recruitment of TBP to the TATA box of the human γ-globin gene Proceedings of the National Academy of Sciences of the United States of America. ,vol. 99, pp. 5509- 5514 ,(2002) , 10.1073/PNAS.072084499
Qiliang Li, Miaohua Zhang, Zhijun Duan, George Stamatoyannopoulos, Structural analysis and mapping of DNase I hypersensitivity of HS5 of the β-globin locus control region Genomics. ,vol. 61, pp. 183- 193 ,(1999) , 10.1006/GENO.1999.5954
Thomas A. Milne, Mary Ellen Martin, Hugh W. Brock, Robert K. Slany, Jay L. Hess, Leukemogenic MLL Fusion Proteins Bind across a Broad Region of the Hox a9 Locus, Promoting Transcription and Multiple Histone Modifications Cancer Research. ,vol. 65, pp. 11367- 11374 ,(2005) , 10.1158/0008-5472.CAN-05-1041
Nicole Spieker, Peter van Sluis, Mabel Beitsma, Kathy Boon, Barbera D.C. van Schaik, Antoine H.C. van Kampen, Huib Caron, Rogier Versteeg, The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32. Genomics. ,vol. 71, pp. 214- 221 ,(2001) , 10.1006/GENO.2000.6408
A Lasa, M J Carnicer, A Aventín, C Estivill, S Brunet, J Sierra, J F Nomdedéu, MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemias. Leukemia. ,vol. 18, pp. 1231- 1237 ,(2004) , 10.1038/SJ.LEU.2403377